Cancer Institute NSW
Publications using our data
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
The capture of anticancer medicine use by the PBS was generally high but varied depending on cancer site. PBS data can be supplemented by MBS and inpatient data, to examine ‘fact of treatment’ with a very high capture.
The risk of developing a subsequent primary melanoma varies considerably between individuals & is particularly high for those with two or more previous melanomas.
Although the probability of death for cancer patients has decreased, there is still the need for improvement in cancer prevention, diagnosis, and treatment.
The health service and diagnostic pathway to diagnosis differs markedly for people notified with CUP compared to those with metastatic cancer of known primary.
Distinct subgroups of patients were less likely to receive radiotherapy. Advocacy and/or policy changes are needed to improve access to radiotherapy.
International variations in ovarian cancer survival by stage were observed, with the largest differences for those in the oldest age group with advanced disease.
Lung cancers in children under the age of 15 are very uncommon, detection can be difficult due to the rarity of the disease and generally non-specific symptoms.
We considered the weight of evidence method to be most suitable for population-level reporting of cancer incidence among Aboriginal people.
The incidence rates of several childhood cancer types steadily increased during 1983-2015.
About 11,000 cancers in women & 18,000 in men may be overdiagnosed each year. See more on estimating the magnitude of cancer overdiagnosis in Australia.
